Are retatrutide and Ozempic the same?

No. Ozempic is a brand name for semaglutide, a GLP-1 drug. Retatrutide is a different investigational molecule that switches on the GLP-1, GIP, and glucagon receptors. TRIUMPH-1 is a retatrutide study (2,339 people; a company release reported up to 28.3% weight loss at 80 weeks on 12 milligrams). STEP 1 used semaglutide 2.4 milligrams in 1,961 adults (down 14.9% at 68 weeks). Those are separate studies of separate drugs. By this site's national fields, retatrutide is not approved in the US, UK, Australia, or Canada. This site does not rank them. Full records at /compounds/retatrutide and /compounds/semaglutide.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.